1. GBD 2016 Risk Factors Collaborators, Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345-422.
2. GBD 2015 Tobacco Collaborators, Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885-906.
3. 2008 PHS Guideline Update Panel, Liaisons, and Staff, Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53(9):1217-22.
4. West R. Tobacco smoking: health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):1018–36.
5. Dobrzanski T, Bizon E. Growth hormone (HGH), IRI and total IRI responses to glucose load in selected groups of mental patients. II. Studies on the so-called chlorthalidone-diabetes in chronic schizophrenics. Endokrynol Polska. 1974;25(6):455–60.